Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)
Clinical trial NCT04202679 · COMPLETED
Trial details
- NCT number
- NCT04202679
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2021-08-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.